Jake Y. Henry
Darlinghurst, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Framework-mediated binding of foreign and self-glycans by IGHV4-34 antibodies.
Journal: Frontiers in immunology
Published: December 15, 2025
Humoral epitope dominance and immune imprinting by SARS-CoV-1 and SARS-CoV-2 vaccines.
Journal: Immunology and cell biology
Published: September 04, 2025
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.
Journal: Science advances
Published: March 12, 2025
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 02, 2025
Human genomic DNA is widely interspersed with i-motif structures.
Journal: The EMBO journal
Published: March 07, 2024
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients.
Journal: Nature communications
Published: January 19, 2022
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia.
Journal: Nature microbiology
Published: December 28, 2021
Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies.
Journal: mAbs
Published: May 24, 2021
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability.
Journal: Immunity
Published: May 19, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026